Abstract:Most of the conventional in vitro models to test biomaterial-driven vascularization are too simplistic to recapitulate the complex interactions taking place in the actual cell microenvironment, which results in a poor prediction of the in vivo performance of the material. However, during the last decade, cell culture models based on microfluidic technology have allowed attaining unprecedented levels of tissue biomimicry. In this work, we propose a microfluidic-based 3D model to evaluate the effect of bioactive biomaterials capable of releasing signaling cues (such as ions or proteins) in the recruitment of endogenous endothelial progenitor cells, a key step in the vascularization process. The usability of the platform is demonstrated using experimentally-validated finite element models and migration and proliferation studies with rat endothelial progenitor cells (rEPCs) and bone marrow-derived rat mesenchymal stromal cells (BM-rMSCs). As a proof of concept of biomaterial evaluation, the response of rEPCs to an electrospun composite made of polylactic acid with calcium phosphates nanoparticles (PLA+CaP) was compared in a co-culture microenvironment with BM-rMSC to a regular PLA control. Our results show a significantly higher rEPCs migration and the upregulation of several pro-inflammatory and proangiogenic proteins in the case of the PLA+CaP. The effects of osteopontin (OPN) on the rEPCs migratory response were also studied using this platform, suggesting its important role in mediating their recruitment to a calcium-rich microenvironment. This new tool could be applied to screen the capacity of a variety of bioactive scaffolds to induce vascularization and accelerate the preclinical testing of biomaterials. STATEMENT OF SIGNIFICANCE: For many years researchers have used neovascularization models to evaluate bioactive biomaterials both in vitro, with low predictive results due to their poor biomimicry and minimal control over cell cues such as spatiotemporal biomolecule signaling, and in vivo models, presenting drawbacks such as being highly costly, time-consuming, poor human extrapolation, and ethically controversial. We describe a compact microphysiological platform designed for the evaluation of proangiogenesis in biomaterials through the quantification of the level of sprouting in a mimicked endothelium able to react to gradients of biomaterial-released signals in a fibrin-based extracellular matrix. This model is a useful tool to perform preclinical trustworthy studies in tissue regeneration and to better understand the different elements involved in the complex process of vascularization.

Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations

Grafting of 3D Bioprinting to in Vitro Drug Screening: A Review

New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity

Microfluidic-Based 3D Engineered Microvascular Networks and Their Applications in Vascularized Microtumor Models

Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies

Blood vessels in a dish: the evolution, challenges, and potential of vascularized tissues and organoids

3D tumor angiogenesis models: recent advances and challenges

Microfluidics in vascular biology research: a critical review for engineers, biologists, and clinicians

The Edifice of Vasculature-On-Chips: A Focused Review on the Key Elements and Assembly of Angiogenesis Models

Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening

Single-cell characterization of neovascularization using hiPSC-derived endothelial cells in a 3D microenvironment

Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications

Microfluidic 3D platform to evaluate endothelial progenitor cell recruitment by bioactive materials

Advances in the differentiation of pluripotent stem cells into vascular cells

3D Human iPSC Blood Vessel Organoids as a Source of Flow‐Adaptive Vascular Cells for Creating a Human‐Relevant 3D‐Scaffold Based Macrovessel Model

Current advances of 3D-bioprinted microfluidic models with hydrogel bioinks and their applications in drug screening

Human Ocular Angiogenesis‐Inspired Vascular Models on an Injection‐Molded Microfluidic Chip

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches